Entering text into the input field will update the search result below

Oncolytics Biotech GAAP EPS of -C$0.14

  • Oncolytics Biotech press release (NASDAQ:ONCY): Q4 GAAP EPS of -C$0.14.
  • Net cash used in operating activities was C$22.4 million for the full year 2021, compared to C$22.1 million for the full year 2020.
  • As of December 31, 2021, the company reported C$41.3 million in cash and cash equivalents.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.